Characteristics | 2018-2019 (n = 164) | 2020-2022 (n = 200) | 2023 (n = 175) | P1-Value | P2-Value |
Gender n(%) |
|
|
| 0.401a | 0.824a |
Male | 99 (60.37) | 112 (56) | 100 (57.14) |
|
|
Female | 65 (39.63) | 88 (44) | 75 (42.86) |
|
|
MFR | 1.52 | 1.27 | 1.33 |
|
|
Median Age (P25-P75) | 24 (16- 38) | 21 (13 - 35) | 28 (15 - 42) | 0.584b | 0.795b |
Age group Month n (%) |
|
|
| 0.388 a | 0.1 a |
<12 | 21 (12.80) | 36 (18) | 21 (12) |
|
|
12 - 23 | 58 (35.37) | 79 (39.5) | 57 (32.57) |
|
|
24 - 35 | 40 (24.39) | 36 (18) | 34 (19.43) |
|
|
36 - 47 | 27 (16.46) | 31 (15.5) | 38 (21.71) |
|
|
≥48 | 18 (10.98) | 18 (9) | 25 (14.29) |
|
|
Serotypes, n (%) |
|
|
| 0.238c | 0.582c |
EV-A71 | 6 (3.66) | 2 (1) | 0 (0) |
|
|
CV-A16 | 26 (15.85) | 35 (17.5) | 33 (18.86) |
|
|
OtherEVs | 132 (80.49) | 163 (81.5) | 142 (81.14) |
|
|